Lead sponsor
UNC Lineberger Comprehensive Cancer Center
2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
2
Trials led
2
Active
60
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Early Phase 1
1
Phase 2
1
Trials by status
Not yet recruiting
1
Recruiting
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial CancerBMI ≥30Ph 2Not yet recruiting40